Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study.
Saved in:
| Title: | Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study. |
|---|---|
| Authors: | Hellmann, Matthew D1 hellmanm@mskcc.org, Rizvi, Naiyer A1, Goldman, Jonathan W2, Gettinger, Scott N3, Borghaei, Hossein4, Brahmer, Julie R5, Ready, Neal E6, Gerber, David E7, Chow, Laura Q8, Juergens, Rosalyn A9, Shepherd, Frances A10, Laurie, Scott A11, Geese, William J12, Agrawal, Shruti12, Young, Tina C12, Li, Xuemei12, Antonia, Scott J13 |
| Source: | Lancet Oncology. Jan2017, Vol. 18 Issue 1, p31-41. 11p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 120475026 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Hellmann%2C+Matthew+D%22">Hellmann, Matthew D</searchLink><relatesTo>1</relatesTo><i> hellmanm@mskcc.org</i><br /><searchLink fieldCode="AR" term="%22Rizvi%2C+Naiyer+A%22">Rizvi, Naiyer A</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Goldman%2C+Jonathan+W%22">Goldman, Jonathan W</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Gettinger%2C+Scott+N%22">Gettinger, Scott N</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Borghaei%2C+Hossein%22">Borghaei, Hossein</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Brahmer%2C+Julie+R%22">Brahmer, Julie R</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Ready%2C+Neal+E%22">Ready, Neal E</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Gerber%2C+David+E%22">Gerber, David E</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Chow%2C+Laura+Q%22">Chow, Laura Q</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Juergens%2C+Rosalyn+A%22">Juergens, Rosalyn A</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Shepherd%2C+Frances+A%22">Shepherd, Frances A</searchLink><relatesTo>10</relatesTo><br /><searchLink fieldCode="AR" term="%22Laurie%2C+Scott+A%22">Laurie, Scott A</searchLink><relatesTo>11</relatesTo><br /><searchLink fieldCode="AR" term="%22Geese%2C+William+J%22">Geese, William J</searchLink><relatesTo>12</relatesTo><br /><searchLink fieldCode="AR" term="%22Agrawal%2C+Shruti%22">Agrawal, Shruti</searchLink><relatesTo>12</relatesTo><br /><searchLink fieldCode="AR" term="%22Young%2C+Tina+C%22">Young, Tina C</searchLink><relatesTo>12</relatesTo><br /><searchLink fieldCode="AR" term="%22Li%2C+Xuemei%22">Li, Xuemei</searchLink><relatesTo>12</relatesTo><br /><searchLink fieldCode="AR" term="%22Antonia%2C+Scott+J%22">Antonia, Scott J</searchLink><relatesTo>13</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Lancet+Oncology%22">Lancet Oncology</searchLink>. Jan2017, Vol. 18 Issue 1, p31-41. 11p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=120475026 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S1470-2045(16)30624-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 11 StartPage: 31 Titles: – TitleFull: Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hellmann, Matthew D – PersonEntity: Name: NameFull: Rizvi, Naiyer A – PersonEntity: Name: NameFull: Goldman, Jonathan W – PersonEntity: Name: NameFull: Gettinger, Scott N – PersonEntity: Name: NameFull: Borghaei, Hossein – PersonEntity: Name: NameFull: Brahmer, Julie R – PersonEntity: Name: NameFull: Ready, Neal E – PersonEntity: Name: NameFull: Gerber, David E – PersonEntity: Name: NameFull: Chow, Laura Q – PersonEntity: Name: NameFull: Juergens, Rosalyn A – PersonEntity: Name: NameFull: Shepherd, Frances A – PersonEntity: Name: NameFull: Laurie, Scott A – PersonEntity: Name: NameFull: Geese, William J – PersonEntity: Name: NameFull: Agrawal, Shruti – PersonEntity: Name: NameFull: Young, Tina C – PersonEntity: Name: NameFull: Li, Xuemei – PersonEntity: Name: NameFull: Antonia, Scott J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: Jan2017 Type: published Y: 2017 Identifiers: – Type: issn-print Value: 14702045 Numbering: – Type: volume Value: 18 – Type: issue Value: 1 Titles: – TitleFull: Lancet Oncology Type: main |
| ResultId | 1 |